Rapid and sustained remission of synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome with IL-23p19 antagonist (risankizumab)

Rapid and sustained remission of synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome with IL-23p19 antagonist (risankizumab)

Bibliographic Details
Main Authors: Akshay Flora, MD, MMed, Richard Holland, MBChB, Annika Smith, MBBS, John W. Frew, MBBS, MMed, MS
Format: Article
Language:English
Published: Elsevier 2021-08-01
Series:JAAD Case Reports
Subjects:
hidradenitis suppurativa
inflammation
interleukin-23
risankizumab
SAPHO
Online Access:http://www.sciencedirect.com/science/article/pii/S2352512621003830

Internet

http://www.sciencedirect.com/science/article/pii/S2352512621003830

Similar Items